sl 11 mimics of neoplasia in the gi tract case 4
play

SL-11 Mimics of neoplasia in the GI tract Case 4 XXXII Congress of - PowerPoint PPT Presentation

SL-11 Mimics of neoplasia in the GI tract Case 4 XXXII Congress of the International Academy of Pathology (IAP) Dead Sea / Jordan October 14-18, 2018 Cord Langner MD Institute of Pathology Medical University Graz / Austria


  1. SL-11 Mimics of neoplasia in the GI tract – Case 4 XXXII Congress of the International Academy of Pathology (IAP) Dead Sea / Jordan – October 14-18, 2018 Cord Langner MD Institute of Pathology Medical University Graz / Austria www.medunigraz.at/ENGIP

  2. Patient History  Colonic biopsies from a 44-year-old male patient  Symptoms: non-bloody diarrhoea since approximately three months  Endoscopy: mild erythematous pancolitis, no mucosal breaks  The patient is under mycophenolate mofetil (MMF) therapy which was initiated after renal transplantation five years previously

  3. Diagnosis I: 2 Mycophenolate mofetil (MMF) associated colitis

  4. 1. Graft versus Host Disease 2. Drug reactions (e.g. mycophenolate mofetil, MMF) 3. Infections related to immunosuppressive therapy (commonly due to viral agents, but also bacteria, e.g. Clostridium difficile ) 4. Post-Transplant Lymphoproliferative Disorder (PTLD) Wong. Histopathology 2015

  5. Selbst et al. Mod Pathol 2009

  6. Liapis et al. Histopathology 2013

  7. Crypt distortion and loss as well as increased apoptosis constituted the main features, their degree and combination leading either to an inflammatory bowel disease (IBD)-like (82%) or to a graft-versus host-disease-like pattern (18%). Liapis et al. Histopathology 2013

  8. Liapis et al. Histopathology 2013

  9. Lee et al. J Clin Pathol 2013

  10. Your diagnosis?

  11. CMV immunohistochemistry

  12. Diagnosis II: 2 Mycophenolate mofetil (MMF) associated colitis plus CMV infection

  13. Is this all ?

  14. Diagnosis III: 2 Mycophenolate mofetil (MMF) associated colitis plus CMV infection plus cryptosporidiosis

  15. Is this a common association? Two out of seven cases were on H&E positive for CMV (confirmed by immunohistochemistry) Five out of ten cases were on H&E positive for CMV (confirmed by immunohistochemistry)

  16. Parfitt & Driman. Hum Pathol 2007

  17. Drug reactions need to be considered in the differential diagnosis of mimics of neoplasia

  18. McCarthy et al. Histopathology 2015

  19. ENGIP Case 3/2015 Chemotherapy-induced colitis (oxaliplatin/capecitabine)

  20. Mitotic Arrest („Ring Mitoses“) with Paclitaxel and Docetaxel MIB-1 p53 Langner und Ott, Histopathology 2007

  21. Daniels et al. Am J Surg Pathol 2008

  22. Crowder et al. Am J Surg Pathol 2009

  23. Take Home Messages  Drug induced injury may be seen in all parts of the gastrointestinal tract and may show a variety of morphological patters  Many of these are unspecific (e.g. necrosis, ulceration), while others are suspicious (e.g. increased epithelial apoptosis)  Drug effects may mimic neoplastic change both on the macroscopic (ulceration, stenosis) and the histological (nuclear atypia, increased mitosis, apoptosis) level  In patients after organ transplantation / under immunosuppression the following conditions need to be considered  Drug reactions (e.g. mycophenolate mofetil, MMF)  Infections related to immunosuppressive therapy (commonly due to viral agents, but also bacteria, e.g. Clostridium difficile)  Graft versus Host Disease  Post-Transplant Lymphoproliferative Disorder (PTLD)

  24. Please save the following date: 3 rd meeting of the Pannonian Working Group of Gastrointestinal Pathology Where and when: Budapest / Hungary, May 10-11, 2019 Topic: Pathology of the small bowel Local organizer: Prof. Bence Kövari (kovari.bence.p@gmail.com)

  25. Thank you very much for your kind attention! Cord Langner MD Institute of Pathology Medical University of Graz / Austria cord.langner@medunigraz.at European Network of Gastrointestinal Pathology www.medunigraz.at/ENGIP www.facebook.com/ENGIP Advanced Training Center of Gastrointestinal Pathology European Society of Pathoogy

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend